Abstract
The effect of noncontrast CT (NCCT) on the eligibility for endovascular therapy (EVT) in an extended time window remains to be elucidated. We sought to assess the efficacy and safety of NCCT in comparison with CT perfusion (CTP) in selecting patients with acute ischemic stroke (AIS) for EVT 6-24hours after onset. PubMed, Embase, and Cochrane libraries were searched from inception to August 31, 2022, to identify all studies reporting 90-day outcomes of EVT in patients with AIS in an extended time window. A meta-analysis was performed for the pooled risk ratio (RR) with 95% confidence interval (CI) using a random-effects model. The primary outcome used to assess efficacy was good functional independence, defined as a modified Rankin Scale score of 0-2 at 90days. Secondary outcomes included successful reperfusion, symptomatic intracranial hemorrhage (sICH), and mortality at 90 days. We included four nonrandomized studies with a total of 2685 patients. The outcomes of good functional independence at 90days (RR=0.98; 95% CI: 0.88-1.07; I2 =0%; p=.62), successful reperfusion (RR=0.98; 95% CI: 0.93-1.03; I2 =50.5%; p=.11), sICH (RR=1.11; 95% CI: 0.55-2.21; I2 =49.4%; p=.12), or mortality at 90days (RR=1.18; 95% CI: 0.99-1.40; I2 =0%; p=.42) did not differ significantly between the two groups. These findings suggest that NCCT is as effective as CTP in selecting patients for EVT in an extended time window.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call